What Cannabis Manufacturers Can Learn from Food Processing

A product recall can disrupt production, strain relationships with distributors, trigger regulatory scrutiny, and undermine consumer confidence. For cannabis manufacturers, the consequences can extend across an entire product portfolio, from extracted oils and infused beverages to gummies, tinctures, topicals, and dietary supplement products.

The underlying causes are often familiar to food processors: microbial contamination, undeclared allergens, inaccurate labeling, inconsistent ingredient quality, packaging failures, or incomplete production records.

Food manufacturers have spent decades developing systems to identify these risks, prevent failures, and remove affected products from distribution. Cannabis manufacturers can learn from those practices, particularly as the industry expands into more sophisticated formulations and larger-scale manufacturing.

The most important lesson is that an effective recall begins long before a product reaches the market. It depends on the quality of the facility’s preventive controls, the reliability of its testing program, the accuracy of its records, and its ability to identify affected products quickly.

For cannabis businesses, applying food-industry recall practices means treating product safety as an integrated operational responsibility rather than a final quality-control checkpoint.

1. Why Cannabis Manufacturers Should Study Food Recalls

Food processing and cannabis manufacturing share many operational challenges. Both industries transform agricultural or botanical raw materials into products intended for consumption or application to the body. Both rely on controlled production environments, validated procedures, reliable suppliers, testing, accurate labeling, and effective distribution records.

However, extraction introduces additional complexities. A contaminant in incoming biomass may persist in an extract, while blending, formulation, and packaging can introduce new hazards or spread an existing problem across multiple finished-product batches.

A single ingredient issue can therefore affect several products, flavors, potencies, or package sizes.

Food recalls demonstrate that a product’s safety cannot be established by relying on one laboratory result or one inspection. It requires controls throughout the manufacturing process. The U.S. Food and Drug Administration (FDA) has emphasized the importance of prompt recall communication, accurate product identification, and effective removal of recalled products from commerce.

FDA

+1

For cannabis manufacturers, this translates into three fundamental questions:

• Can the company identify the specific products and batches affected by a potential hazard?
• Can it determine which customers, distributors, and retail locations received those products?
• Can it stop additional shipments and verify that affected inventory has been removed from sale?

If these questions cannot be answered quickly, even a limited quality issue can become a broader business and public-health problem.

2. Common Recall Triggers in Cannabis and Botanical Processing

Understanding the causes of recalls is the first step toward preventing them. Cannabis manufacturers should evaluate hazards based on the ingredients they use, their extraction methods, their product formats, and the conditions under which products are manufactured and stored.

Microbial contamination

Raw cannabis and hemp materials may carry microorganisms introduced during cultivation, harvesting, drying, storage, or transportation. Poor sanitation, inadequate environmental controls, and post-processing contamination can create additional risks.

Depending on the product and process, manufacturers may need to evaluate risks associated with Salmonella, pathogenic E. coli, molds, and other microorganisms.

Extraction should not automatically be treated as a validated microbial control step. Its effectiveness depends on the specific process, operating conditions, equipment, and organism involved. Further, a product may become contaminated after extraction during blending, filling, or packaging.

Operational lesson: Establish risk-based microbial specifications for incoming materials and finished products, validate relevant control steps, and monitor sanitation throughout the facility.

Chemical contaminants and residual solvents

Cannabis and hemp extracts may require evaluation for pesticides, heavy metals, residual solvents, and other chemical contaminants. The applicable testing panel depends on the product, process, jurisdiction, and intended use.

Extraction can concentrate certain compounds along with desired constituents. Solvents used during extraction may also remain in the finished material if removal is inadequate.

A compliant incoming-material certificate does not eliminate the need to evaluate downstream risks. Manufacturers should understand the limitations of supplier testing and determine which controls and independent verification tests are appropriate.

Operational lesson: Qualify suppliers, review certificates of analysis, establish acceptance criteria, and investigate results that fall outside specifications before materials enter production.

Incorrect potency and formulation

Potency-related problems can affect consumer safety, product consistency, and regulatory compliance. Inaccurate ingredient dosing, inadequate mixing, formulation errors, or unreliable analytical methods can result in products that contain different concentrations of active ingredients than their labels indicate.

For infused gummies, beverages, tinctures, and other products, manufacturers should pay particular attention to batch homogeneity and dosage uniformity.

Operational lesson: Validate mixing and dosing procedures, control ingredient additions, reconcile material quantities, and use appropriate analytical testing to confirm product specifications.

Labeling and packaging failures

Food-industry recalls frequently involve undeclared allergens or inaccurate product information. Cannabis manufacturers face comparable risks involving incorrect potency declarations, missing warnings, inconsistent ingredient statements, and packaging that does not meet applicable requirements.

A packaging-line mix-up can result in a correctly manufactured product being placed in the wrong container. This may affect multiple batches if the same labeling error continues unnoticed.

Operational lesson: Verify labels against approved specifications, reconcile printed packaging materials, perform documented line clearances, and confirm lot codes and expiration or best-by dates where applicable.

3. Build Traceability Into Every Production Stage

Traceability is one of the most important lessons cannabis manufacturers can take from food processing.

A batch number printed on a finished product is not sufficient on its own. The number must connect to reliable records showing where ingredients came from, how the product was made, which quality checks were performed, and where the finished goods were shipped.

A practical traceability system should link the following stages.

1. Supplier and receiving records

Document supplier identity, ingredient lot numbers, receiving dates, certificates of analysis, inspection results, and acceptance or rejection decisions.

2. Extraction and processing records

Connect input lots to extraction runs, equipment, processing parameters, operator records, intermediate materials, and deviations.

3. Formulation and quality testing

Link extracts and other ingredients to formulation records, finished-product batches, laboratory results, and quality-release decisions.

4. Packaging and distribution

Record finished lot codes, packaging identifiers, quantities released, shipment dates, direct customers, and distribution destinations.

This structure supports both backward tracing and forward tracing. Backward tracing identifies the source of a problem; forward tracing identifies every affected product and recipient.

The FDA’s Food Safety Modernization Act (FSMA) includes traceability requirements for certain designated foods. As of October 2026, the FDA states that the additional Food Traceability Rule requirements are not to be enforced before July 20, 2028, following congressional direction. The rule does not apply universally to every food or every cannabis product, and manufacturers must assess its scope and any exemptions rather than assume coverage.

FDA

+1

Even when a particular rule does not apply, the underlying principle remains valuable: manufacturers should be able to trace ingredients through production and finished products through distribution without reconstructing the entire history manually.

4. Treat Recall Prevention as Part of a HACCP-Based Food Safety System

Food processors use hazard analysis and preventive controls to identify risks before products reach consumers. Cannabis manufacturers can adopt the same risk-based approach, tailored to their products and applicable legal requirements.

Hazard Analysis and Critical Control Points (HACCP) is a systematic method for identifying hazards, determining where controls are needed, setting limits where appropriate, monitoring performance, and responding when controls fail.

A HACCP-based approach should begin with a clear understanding of the product and process. A manufacturer producing a shelf-stable infused gummy faces different risks from one producing a refrigerated beverage, a botanical tincture, or a topical formulation.

A useful hazard assessment considers:

• Biological hazards: Pathogens, spoilage organisms, and contamination introduced by people, equipment, water, or the environment.
• Chemical hazards: Pesticides, residual solvents, cleaning chemicals, heavy metals, and unintended ingredient carryover.
• Physical hazards: Metal fragments, glass, hard plastic, and other foreign materials.
• Formulation and labeling hazards: Incorrect ingredient quantities, potency errors, undeclared allergens, and packaging mix-ups.

The company should then identify appropriate preventive controls, monitoring procedures, corrective actions, verification activities, and recordkeeping requirements.

For facilities subject to FDA’s Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food regulation, 21 CFR Part 117, specific requirements apply, including a written recall plan when required under § 117.139. Applicability depends on the product, facility, and any relevant exemptions. State cannabis rules and other federal requirements may impose additional or different obligations.

FDA

+1

A written plan should be supported by actual operating practices. A documented procedure cannot compensate for poor sanitation, unreliable testing, weak supplier controls, or incomplete production records.

5. Laboratory Testing Is a Verification Tool, Not a Complete Safety Strategy

Cannabis manufacturers often rely on third-party laboratories to confirm product quality and regulatory compliance. Testing is essential, but its value depends on sampling, analytical methods, sample handling, and the decisions made in response to results.

One of the most common mistakes is assuming that a passing result proves an entire production lot is free from every relevant hazard.

A laboratory analyzes the material submitted for testing. If the sample is not representative of the batch, contamination or inconsistency elsewhere in the lot may go undetected. Similarly, a test for one contaminant cannot establish the absence of hazards outside the scope of that method.

Manufacturers should build a testing program around product-specific risk assessments.

Practical measures include:

1. Establishing written specifications for incoming materials, in-process materials, and finished products.
2. Defining sampling plans that account for batch size, process variability, and the nature of the hazard.
3. Confirming that laboratories use suitable, validated analytical methods for the intended purpose.
4. Establishing procedures for out-of-specification and suspect results, including investigation and documented disposition.
5. Preventing the release of affected products until required quality reviews are complete.

Where results indicate a possible safety issue, the response should extend beyond simply requesting a retest. The manufacturer should investigate the original result, assess related batches, determine whether the issue may have affected products already distributed, and document the basis for its decisions.

Retesting should not be used to dismiss an unfavorable result without a scientifically justified investigation.

6. Prepare a Written Recall Plan Before an Incident Occurs

A recall plan should function as an operational playbook, not simply a document stored in a quality manager’s office.

Food manufacturers subject to 21 CFR Part 117 generally must maintain a written recall plan when required by § 117.139. The regulation addresses direct consignee notification, public notification when appropriate, effectiveness checks, and product disposition.

FDA

Cannabis manufacturers should develop procedures appropriate to their own products, licensing requirements, and regulatory obligations.

A practical recall plan should define the following responsibilities.

Recall activity	Key operational requirement
Incident assessment	Evaluate the suspected hazard, affected products, and potential consumer exposure.
Shipment hold	Stop the release or shipment of potentially affected inventory.
Batch identification	Determine affected ingredient lots, production runs, package codes, and finished products.
Distribution tracing	Identify distributors, retailers, and other direct customers who received affected goods.
Regulatory communication	Determine which agencies must be notified, under which rules, and within what time frames.
Product recovery	Issue clear instructions for quarantining, returning, or otherwise managing affected inventory.
Final disposition	Document authorized reprocessing, destruction, or other legally permitted disposition.
Corrective action	Investigate the root cause and implement measures to prevent recurrence.

One detail deserves particular attention: a recall is not complete simply because a manufacturer has sent an email to its distributors.

The company must have a process for confirming that notifications were received, affected products were identified correctly, and inventory was removed from distribution. The FDA’s December 2025 industry letter highlighted real-world cases in which recalled products remained available for sale after recall notifications had been issued.

FDA

For cannabis businesses operating through licensed dispensaries and distribution networks, this lesson is especially relevant. A company needs reliable contact information, documented acknowledgments, clear lot-identification instructions, and a method for following up on outstanding responses.

Conduct mock recalls

Mock recalls help determine whether the plan works under realistic conditions.

Select a finished-product lot and ask the team to identify its raw material sources, production records, laboratory results, packaging records, and distribution destinations. Set a defined completion target based on the company’s risk profile, then measure actual performance.

A useful exercise should answer:

• How long does it take to identify all affected finished-product lots?
• Can the team identify every direct customer that received the product?
• Do ingredient and finished-product quantities reconcile?
• Are shipment records complete and accessible?
• Can the company distinguish affected inventory from unaffected products?
• Can personnel locate and execute the correct notification procedures?

Document gaps, assign corrective actions, and repeat the exercise to verify improvement.

7. Design Facilities to Support Contamination Prevention

Food safety also depends on the physical environment in which products are manufactured.

Poor facility layouts can increase the risk of cross-contamination, make sanitation more difficult, and create opportunities for material mix-ups. These problems may not be obvious during routine production but can become significant when an investigation begins.

Cannabis extraction and formulation facilities should consider several design principles.

Separation of activities. Receiving, raw-material storage, extraction, post-processing, formulation, packaging, and finished-goods storage should be arranged to control relevant contamination and mix-up risks. The degree of separation should reflect the products, hazards, process, and applicable requirements.

Personnel and material flow. Movement between areas should be planned to reduce unnecessary crossings between raw materials, processing equipment, waste, and finished goods.

Sanitation access. Equipment and room layouts should allow effective cleaning, inspection, maintenance, and verification. Difficult-to-clean surfaces and inaccessible equipment connections can create persistent contamination risks.

Environmental control. Temperature, humidity, ventilation, and other environmental conditions should be appropriate to the materials and products being handled. Where environmental monitoring is warranted, results should be reviewed for patterns rather than treated as isolated readings.

Storage and quarantine. Facilities should provide clearly designated areas for incoming materials awaiting approval, rejected ingredients, products awaiting testing or release, and recalled or otherwise restricted inventory.

These design considerations should be incorporated early in facility planning. Retrofitting a poorly arranged production space can be expensive, particularly when equipment, utilities, personnel routes, and sanitation procedures are already established.

Facility design does not replace a validated food safety program. It supports the program by making correct operating practices easier to implement consistently.

8. Understand the Regulatory Boundaries for Cannabis Products

Lessons from food processing are valuable, but cannabis manufacturers must avoid assuming that all cannabis products are regulated identically to conventional foods.

In the United States, the applicable framework depends on the product’s ingredients, intended use, claims, manufacturing activities, distribution channels, and state or federal jurisdiction.

The FDA states that introducing food containing added THC or CBD into interstate commerce is prohibited under the Federal Food, Drug, and Cosmetic Act, subject to the statute’s applicable exceptions. The agency also distinguishes among foods, dietary supplements, cosmetics, and drug products.

FDA

+1

Consequently, a cannabis-infused gummy, hemp-derived topical, botanical extract, and prescription cannabinoid drug should not automatically be treated as subject to the same requirements.

Manufacturers should review the relevant requirements before commercializing a product, including:

• Applicable state cannabis licensing, testing, labeling, and recall rules.
• FDA requirements relevant to the product’s legal classification and intended use.
• USDA requirements where applicable to agricultural materials or regulated activities.
• Good manufacturing practice requirements applicable to the specific product category.
• State and local requirements for facility operations, sanitation, waste handling, and inspections.
• Reporting, notification, and record-retention obligations associated with safety incidents.

The Food Traceability Rule also deserves careful review for businesses handling covered foods. Its additional recordkeeping provisions apply to designated foods and qualifying activities, subject to applicable exemptions; they should not be interpreted as a universal cannabis traceability mandate.

FDA

Regulatory counsel and qualified compliance personnel should assess the specific operation. A robust internal recall system can improve preparedness, but it does not itself establish that a product is legally marketable or that every regulatory obligation has been met.

9. A Practical Recall-Readiness Checklist for Cannabis Manufacturers

Executives and facility operators can use the following checklist to assess their current level of preparedness.

Recall-readiness self-assessment

0/12

Preventive controls

Document product-specific hazard assessments.

Qualify suppliers and establish incoming-material specifications.

Validate relevant processing, sanitation, and formulation controls.

Traceability and testing

Link ingredient lots to extraction and finished-product batches.

Connect laboratory results and release decisions to lot records.

Maintain accurate packaging, inventory, and shipment records.

Recall execution

Assign a recall coordinator and backup decision-makers.

Maintain current distributor and customer contact records.

Define shipment holds, notifications, effectiveness checks, and product disposition procedures.

Verification and improvement

Conduct and document mock recalls.

Measure traceability speed and inventory reconciliation accuracy.

Investigate deviations and verify corrective actions are effective.

Reset checklistCopy assessment

This checklist is an operational self-assessment, not a certification of regulatory compliance.

The results should be reviewed by operations, quality assurance, compliance, and leadership. Any unchecked item should be evaluated for risk, ownership, and corrective action rather than treated as a purely administrative gap.

Conclusion: Build Recall Readiness Into Everyday Operations

Cannabis manufacturers can draw an important lesson from food processing: product recalls are easier to manage when safety, traceability, and accountability are built into the manufacturing system from the beginning.

Preventive controls reduce the likelihood of contamination. Reliable laboratory testing helps verify product quality. Integrated batch records make it possible to identify affected inventory. Clear responsibilities and rehearsed procedures help ensure that a recall can be executed promptly when prevention fails.

These systems also support commercial performance. Better traceability can reduce the scope of an investigation, limit unnecessary product losses, and help preserve relationships with distributors and customers. Consistent documentation can make quality reviews and regulatory inspections more manageable.

No manufacturer can eliminate every risk. The objective is to identify hazards early, respond decisively when problems occur, and demonstrate that corrective action addresses the underlying cause.

For cannabis and botanical extract businesses, recall readiness should be treated as a core measure of manufacturing maturity. A company that can reliably explain what went into a product, how it was produced, whether it met specifications, and where it went is better positioned to protect consumers and maintain operational continuity.

The best time to prepare for a recall is before one becomes necessary.